Compare · NITO vs UAN
NITO vs UAN
Side-by-side comparison of N2OFF Inc. (NITO) and CVR Partners LP (UAN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NITO and UAN operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- UAN carries a market cap of $1.30B.
- Over the past year, NITO is down 86.5% and UAN is up 40.2% - UAN leads by 126.7 points.
- UAN has hit the wire 1 time in the past 4 weeks while NITO has been quiet.
PerformanceNITO-86.45%UAN+29.53%
2025-07-28+0.00%2026-02-25
- Company
- N2OFF Inc.
- CVR Partners LP
- Price
- $1.25+32.98%
- $123.88-0.04%
- Market cap
- -
- $1.30B
- 1M return
- -15.54%
- +13.12%
- 1Y return
- -86.45%
- +40.21%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2011
- News (4w)
- 0
- 1
- Recent ratings
- 0
- 0
UAN
CVR Partners LP
CVR Partners, LP, together with its subsidiaries, produces and distributes nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea and ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was founded in 2007 and is based in Sugar Land, Texas.
Latest NITO
- SEC Form PRE 14A filed by N2OFF Inc.
- N2OFF Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- N2OFF Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
- N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
- MitoCareX Bio Reports Successful Results in Vitro: MITOLINE™-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases
- Chief Executive Officer Palach David was granted 100,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Controller Zakai Shlomo was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Director Weiss Amitay was granted 116,286 units of Restricted Shares of Common Stock (SEC Form 4)
- Chief Financial Officer Barda Lital was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- In Spaceflight Conditions: N2OFF's MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions
Latest UAN
- CVR Partners to Release Second Quarter 2026 Earnings Results
- New insider Roberts Richard J. Jr. claimed ownership of 517 units of Common Units (SEC Form 3)
- CVR Partners 2025 Schedule K-3 Now Available
- CVR Energy and CVR Partners Announce Leadership Changes
- SEC Form 10-Q filed by CVR Partners LP
- CVR Partners LP filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- CVR Partners Reports First Quarter 2026 Results
- CVR Partners to Release First Quarter 2026 Earnings Results
- SEC Form 3 filed by new insider Turbidy Trevor
- CVR Partners LP filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits